Table 5 Proportions of stroke progression and different in-hospital complications after AIS according to quartiles of serum TBA
Variables | Total | Q 1 ≤3.0 (1.8) | Q 2 3.0-5.7 (4.4) | Q 3 5.7-9.5 (7.3) | Q 4 >9.5 (12.7) | P-value |
|---|---|---|---|---|---|---|
stroke progression, n (%) | 115 (14.8%) | 28 (14.2%) | 30 (15.4%) | 33 (17.3%) | 24 (12.4%) | 0.584 |
At least one complication, n (%) | 222 (28.6%) | 59 (29.9%) | 57 (29.2%) | 51 (26.7%) | 55 (28.4%) | 0.906 |
Pneumonia, n (%) | 91 (11.7%) | 27 (13.7%) | 26 (13.3%) | 16 (8.4%) | 22 (11.3%) | 0.343 |
UTI, n (%) | 71 (9.1%) | 15 (7.6%) | 19 (9.7%) | 17 (8.9%) | 20 (10.3%) | 0.808 |
HT, n (%) | 74 (9.5%) | 24 (12.2%) | 20 (10.3%) | 19 (9.9%) | 11 (5.7%) | 0.163 |
GIB, n (%) | 16 (2.1%) | 3 (1.5%) | 2 (1.0%) | 4 (2.1%) | 7 (3.6%) | 0.344 |
Seizures, n (%) | 7 (0.9%) | 1 (0.5%) | 2 (1.0%) | 3 (1.6%) | 1 (0.5%) | 0.585 |
Renal insufficiency, n (%) | 19 (2.4%) | 1 (0.5%) | 7 (3.6%) | 6 (3.1%) | 5 (2.6%) | 0.143 |